about
B-Raf and the inhibitors: from bench to bedsideA form of the metabolic syndrome associated with mutations in DYRK1BRelief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomasRenal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International NetworkAmeloblastoma: A Review of Recent Molecular Pathogenetic DiscoveriesCurrent and future molecular profiling of cancer by next-generation sequencingCurrent and emerging treatment options for hairy cell leukemiaDeciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolutionUniverses collide: combining immunotherapy with targeted therapy for cancerApplications of next-generation sequencing to blood and marrow transplantationTargeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicineBRAF Mutation in Hairy Cell LeukemiaEmerging patterns of somatic mutations in cancerTargeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancersSystems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicineTargeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyondClinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondCIViC databaseRaf-interactome in tuning the complexity and diversity of Raf function.Somatic STAT3 mutations in large granular lymphocytic leukemiaRecurrent SETBP1 mutations in atypical chronic myeloid leukemiaActivating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaImmunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastasesExome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemiaReal-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemiaMyelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical modelsSurveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal GenomicsRenal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.Cooperation between Noncanonical Ras Network Mutations.MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies.Development of hairy cell leukemia in familial platelet disorder with predisposition to acute myeloid leukemia.Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaClass II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.Molecular Testing in Patients with Suspected Myelodysplastic Syndromes.Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation.
P2860
Q21198860-E13A2E13-EC9A-4593-B5E7-EE9E15D0FEC4Q24297819-4B82F44D-1A9C-40EC-AE48-C60A9FB86E44Q24303940-5F58F706-A99F-4C2E-8095-23644613872CQ26764883-171E1856-4875-47AF-A0CD-AACDC4C3A77BQ26781648-6BF0A62C-1CF2-4119-B79C-340B028F9BC3Q26796272-9688DE60-0A20-4713-BFBF-F0034C92340CQ26796423-75C4B733-519B-45E6-B1C9-39620079571FQ26823586-0C894A1C-FA8A-4A7A-A3DA-D2DF6B35BBD0Q26825316-3A84AE67-C8E2-4856-A352-5E4B9222FA67Q26852890-B16FB6F1-D231-4FB8-8F35-96D1F1A10111Q26865436-9828E28A-1D1D-4AD1-8435-E1364ED89251Q27014016-854095C7-89AE-44D9-9636-C0C5FF17B218Q27014126-2902DB84-B46D-4128-8971-831305B46840Q27022240-A04B37D6-B987-4FAC-8AA3-A5F49C4E5EAFQ27024626-EF2DE36B-CBF9-457B-8A19-C77CA0D5E079Q27026323-3470072A-DADB-4A3C-82E4-BA350080323CQ27027493-8DAAB071-33EB-47CE-95B1-ECCD01E3EE2BQ27612411-F48E1C85-A774-4C13-AE6A-D42339CC30C5Q27692653-F3AEBA0D-2D57-4C2E-A527-D3C03676CA1EQ27851792-DA37A50F-B8D9-4E7A-8CED-C64A0209E97EQ27851991-6F29FA51-3742-4B8A-B668-375143B16A1AQ27852067-1B403BDA-BCD8-4C72-8892-5847D2F95200Q27853146-2FED69A3-E9D3-473C-8344-9A1784F67A1BQ27853199-29706A69-04C2-4582-8DA3-CAE044953B0AQ27853209-D699A290-8990-4C0C-ABCC-197EDB5472E1Q28250795-1845D29E-C553-4F60-BB13-5524C9FECB08Q28255147-C583F68D-860E-426D-8E25-9E51C22ED3FDQ28257512-2DA52A8A-C209-4E26-92F2-5FA25B5DAF62Q28387115-24A3AA2B-BCC6-432F-B069-2B107D8F62ADQ28486219-D4ACDC63-C319-43AF-92ED-A4A8B65C7F1EQ28542977-C8221920-45A9-482E-8519-A81498CF70D1Q30275870-297069E4-7854-4BEE-98C3-4FA95132D58BQ30300930-467882A0-5D8A-4936-8553-2481D8CFC2F5Q30412320-E21664BA-6FEB-4328-B1DE-9D6E1D487993Q30458424-29211173-D205-4E57-AA42-EE44A606A5E6Q33409963-ED2A2009-9EF7-48B4-B470-2F898B1D3EC7Q33415584-60F02577-0499-409D-BB0F-D97139AFFA1DQ33415933-DA6A179C-1073-4E5F-AC18-AAB2E59F018CQ33435980-DC16DF4B-F204-4BBB-99CC-24EEDD274963Q33560698-C80352F5-33D9-420B-9AD3-F36AF4639B6A
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
BRAF mutations in hairy-cell leukemia
@ast
BRAF mutations in hairy-cell leukemia
@en
BRAF mutations in hairy-cell leukemia
@nl
type
label
BRAF mutations in hairy-cell leukemia
@ast
BRAF mutations in hairy-cell leukemia
@en
BRAF mutations in hairy-cell leukemia
@nl
altLabel
BRAFMutations in Hairy-Cell Leukemia
@en
prefLabel
BRAF mutations in hairy-cell leukemia
@ast
BRAF mutations in hairy-cell leukemia
@en
BRAF mutations in hairy-cell leukemia
@nl
P2093
P2860
P50
P3181
P356
P1476
BRAF mutations in hairy-cell leukemia.
@en
P2093
Achille Ambrosetti
Alessandra Pucciarini
Alessandro Pulsoni
Antony Holmes
Arcangelo Liso
Barbara Bigerna
Caterina Patti
Enrico Tiacci
Giorgio Inghirami
Giovanni Pizzolo
P2860
P304
P3181
P356
10.1056/NEJMOA1014209
P407
P50
P577
2011-06-16T00:00:00Z